Effects of combined administration of L-tryptophan and tricyclic antidepressants on α2- and β-adrenoceptors and monoamine levels in rat brain
dc.contributor.author | Russell V.A. | |
dc.contributor.author | Lamm M.C.L. | |
dc.contributor.author | De Villiers A.S. | |
dc.contributor.author | Russell V.A. | |
dc.contributor.author | Lamm M.C.L. | |
dc.contributor.author | De Villiers A.S. | |
dc.date.accessioned | 2011-05-15T16:17:29Z | |
dc.date.accessioned | 2011-05-15T16:17:29Z | |
dc.date.available | 2011-05-15T16:17:29Z | |
dc.date.available | 2011-05-15T16:17:29Z | |
dc.date.issued | 1985 | |
dc.date.issued | 1985 | |
dc.description.abstract | In order to test whether co-administration of a serotonin precursor with antidepressant drugs could potentiate the effects of the antidepressants on monoamines or adrenoceptors in rat brain, L-tryptophan (20 mg/kg) was administered to rats daily for 7 or 15 days, either alone or in combination with desipramine (10 mg/kg) or amitriptyline (10 mg/kg). After treatment with L-tryptophan for 7 days, increases were observed in rat hypothalamic and frontal cortex 5-hydroxy-3-indoleacetic acid levels as well as in hypothalamic dopamine and nucleus accumbens 3,4-dihydroxyphenylacetic acid levels. After 15 days, hippocampal β-adrenoceptor density was found to be decreased. There was no evidence of potentiation of desipramine or amitriptyline action when L-tryptophan was administered in combination with the antidepressants. On the contrary, the antidepressants appeared to interact with L-tryptophan to reduce its effects. | |
dc.description.abstract | In order to test whether co-administration of a serotonin precursor with antidepressant drugs could potentiate the effects of the antidepressants on monoamines or adrenoceptors in rat brain, L-tryptophan (20 mg/kg) was administered to rats daily for 7 or 15 days, either alone or in combination with desipramine (10 mg/kg) or amitriptyline (10 mg/kg). After treatment with L-tryptophan for 7 days, increases were observed in rat hypothalamic and frontal cortex 5-hydroxy-3-indoleacetic acid levels as well as in hypothalamic dopamine and nucleus accumbens 3,4-dihydroxyphenylacetic acid levels. After 15 days, hippocampal β-adrenoceptor density was found to be decreased. There was no evidence of potentiation of desipramine or amitriptyline action when L-tryptophan was administered in combination with the antidepressants. On the contrary, the antidepressants appeared to interact with L-tryptophan to reduce its effects. | |
dc.description.version | Article | |
dc.description.version | Article | |
dc.identifier.citation | Neurochemical Research | |
dc.identifier.citation | 10 | |
dc.identifier.citation | 12 | |
dc.identifier.citation | Neurochemical Research | |
dc.identifier.citation | 10 | |
dc.identifier.citation | 12 | |
dc.identifier.issn | 03643190 | |
dc.identifier.issn | 03643190 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14235 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14235 | |
dc.subject | alpha 2 adrenergic receptor; amitriptyline; beta adrenergic receptor; desipramine; monoamine; radioisotope; tricyclic antidepressant agent; tryptophan; 4 aminoclonidine h 3; animal cell; animal experiment; brain; central nervous system; dihydroalprenolol h 3; dopamine brain level; dose response; drug comparison; drug interaction; drug potentiation; drug receptor binding; drug response; intraperitoneal drug administration; nonhuman; pharmacokinetics; priority journal; rat; Amitriptyline; Animal; Antidepressive Agents, Tricyclic; Brain Chemistry; Catecholamines; Desipramine; Drug Combinations; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Support, Non-U.S. Gov't; Time Factors; Tryptophan | |
dc.subject | alpha 2 adrenergic receptor | |
dc.subject | amitriptyline | |
dc.subject | beta adrenergic receptor | |
dc.subject | desipramine | |
dc.subject | monoamine | |
dc.subject | radioisotope | |
dc.subject | tricyclic antidepressant agent | |
dc.subject | tryptophan | |
dc.subject | 4 aminoclonidine h 3 | |
dc.subject | animal cell | |
dc.subject | animal experiment | |
dc.subject | brain | |
dc.subject | central nervous system | |
dc.subject | dihydroalprenolol h 3 | |
dc.subject | dopamine brain level | |
dc.subject | dose response | |
dc.subject | drug comparison | |
dc.subject | drug interaction | |
dc.subject | drug potentiation | |
dc.subject | drug receptor binding | |
dc.subject | drug response | |
dc.subject | intraperitoneal drug administration | |
dc.subject | nonhuman | |
dc.subject | pharmacokinetics | |
dc.subject | priority journal | |
dc.subject | rat | |
dc.subject | Amitriptyline | |
dc.subject | Animal | |
dc.subject | Antidepressive Agents, Tricyclic | |
dc.subject | Brain Chemistry | |
dc.subject | Catecholamines | |
dc.subject | Desipramine | |
dc.subject | Drug Combinations | |
dc.subject | Kinetics | |
dc.subject | Male | |
dc.subject | Rats | |
dc.subject | Rats, Inbred Strains | |
dc.subject | Receptors, Adrenergic, alpha | |
dc.subject | Receptors, Adrenergic, beta | |
dc.subject | Support, Non-U.S. Gov't | |
dc.subject | Time Factors | |
dc.subject | Tryptophan | |
dc.title | Effects of combined administration of L-tryptophan and tricyclic antidepressants on α2- and β-adrenoceptors and monoamine levels in rat brain | |
dc.title | Effects of combined administration of L-tryptophan and tricyclic antidepressants on α2- and β-adrenoceptors and monoamine levels in rat brain | |
dc.type | Article | |
dc.type | Article |